NUDT16L1
Basic information
Region (hg38): 16:4693562-4695859
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUDT16L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 3 | 0 |
Variants in NUDT16L1
This is a list of pathogenic ClinVar variants found in the NUDT16L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-4693746-C-T | not specified | Uncertain significance (Dec 12, 2024) | ||
16-4693759-G-T | not specified | Uncertain significance (Oct 19, 2024) | ||
16-4693763-A-G | not specified | Uncertain significance (Apr 25, 2022) | ||
16-4693872-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
16-4693987-C-T | not specified | Uncertain significance (Jun 22, 2023) | ||
16-4694090-T-C | not specified | Uncertain significance (Jan 03, 2025) | ||
16-4694103-G-C | not specified | Uncertain significance (Dec 12, 2023) | ||
16-4694135-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
16-4694153-C-T | not specified | Uncertain significance (Mar 06, 2025) | ||
16-4694177-C-T | not specified | Uncertain significance (Feb 09, 2025) | ||
16-4694194-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
16-4694197-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
16-4694960-G-A | not specified | Likely benign (Jan 07, 2025) | ||
16-4694963-G-A | not specified | Likely benign (Dec 23, 2024) | ||
16-4694974-G-C | not specified | Uncertain significance (Feb 19, 2025) | ||
16-4694993-G-A | not specified | Likely benign (Dec 01, 2024) | ||
16-4695014-C-A | not specified | Uncertain significance (Feb 13, 2024) | ||
16-4695023-C-T | not specified | Likely benign (Sep 29, 2023) | ||
16-4695029-C-T | not specified | Likely benign (Aug 14, 2023) | ||
16-4695046-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
16-4695078-G-T | not specified | Uncertain significance (Oct 29, 2021) | ||
16-4695096-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
16-4695104-G-C | not specified | Uncertain significance (Oct 22, 2024) | ||
16-4695144-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
16-4695145-A-C | not specified | Uncertain significance (Jul 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NUDT16L1 | protein_coding | protein_coding | ENST00000304301 | 3 | 2166 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000125 | 0.408 | 125582 | 0 | 18 | 125600 | 0.0000717 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.763 | 93 | 116 | 0.801 | 0.00000615 | 1307 |
Missense in Polyphen | 24 | 43.508 | 0.55162 | 491 | ||
Synonymous | -5.91 | 114 | 57.1 | 1.99 | 0.00000335 | 448 |
Loss of Function | 0.139 | 6 | 6.38 | 0.940 | 3.60e-7 | 64 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000405 | 0.000405 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000692 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000194 | 0.0000176 |
Middle Eastern | 0.0000692 | 0.0000544 |
South Asian | 0.0000370 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of TP53BP1 required to stabilize TP53BP1 and regulate its recruitment to chromatin (PubMed:28241136). In absence of DNA damage, interacts with the tandem Tudor-like domain of TP53BP1, masking the region that binds histone H4 dimethylated at 'Lys-20' (H4K20me2), thereby preventing TP53BP1 recruitment to chromatin and maintaining TP53BP1 localization to the nucleus (PubMed:28241136). Following DNA damage, ATM-induced phosphorylation of TP53BP1 and subsequent recruitment of RIF1 leads to dissociate NUDT16L1/TIRR from TP53BP1, unmasking the tandem Tudor-like domain and allowing recruitment of TP53BP1 to DNA double strand breaks (DSBs) (PubMed:28241136). Binds U8 snoRNA (PubMed:18820299). {ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:28241136}.;
- Pathway
- Proteoglycans in cancer - Homo sapiens (human);Syndecan-4-mediated signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.154
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.309
- hipred
- N
- hipred_score
- 0.282
- ghis
- 0.498
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.230
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nudt16l1
- Phenotype
Gene ontology
- Biological process
- negative regulation of double-strand break repair via nonhomologous end joining
- Cellular component
- nucleus
- Molecular function
- RNA binding;protein binding;snoRNA binding;protein homodimerization activity;m7G(5')pppN diphosphatase activity